Immunovant IMVT
NASDAQ IMVT
$33.62 -0.03 (-0.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunovant (IMVT) Depreciation and Depletion (2019 - 2026)

Updated

Immunovant's Depreciation and Depletion was $92,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 14.0% from $107,000 a year earlier and down 4.2% from the prior quarter.

Analysis

Immunovant (IMVT) Depreciation and Depletion (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Immunovant's Depreciation and Depletion was $394,000 through Jun 30, 2026, down 2.5% year-over-year; for FY2026 (ended Mar 31, 2026), it was $409,000, up 8.5% from FY2025.

  • Depreciation and Depletion has now increased for seven consecutive fiscal years, with a five-year compound annual growth rate of 44.5% (FY2021 to FY2026).
  • In earlier fiscal years, Depreciation and Depletion was $377,000 in FY2025 (+63.2%), $231,000 in FY2024 (+19.7%), $193,000 in FY2023 (+53.2%) and $126,000 in FY2022 (+93.8%).
  • The fiscal Q1 2027 figure marks the lowest quarterly Depreciation and Depletion since fiscal Q2 2025.
  • Compared with a year earlier, Depreciation and Depletion was higher in six of the last eight quarters, with growth averaging 28.5%.
  • The best year-over-year quarter for Depreciation and Depletion over five years was fiscal Q2 2022 (growth of 100.0%); the worst was fiscal Q1 2027 (a decline of 14.0%).
  • Per Business Quant data, IMVT's Depreciation and Depletion in the three fiscal quarters before Q1 2027 was $96,000 (Q4 2026), $101,000 (Q3 2026) and $105,000 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Immunovant 6.94 Bn 6.94 Bn - 92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 92,000.00
Mar 31, 2026 96,000.00
Dec 31, 2025 101,000.00
Sep 30, 2025 105,000.00
Jun 30, 2025 107,000.00
Mar 31, 2025 109,000.00
Dec 31, 2024 99,000.00
Sep 30, 2024 89,000.00
Jun 30, 2024 80,000.00
Mar 31, 2024 64,000.00
Dec 31, 2023 58,000.00
Sep 30, 2023 56,000.00
Jun 30, 2023 53,000.00
Mar 31, 2023 54,000.00
Dec 31, 2022 49,000.00
Sep 30, 2022 46,000.00
Jun 30, 2022 44,000.00
Mar 31, 2022 39,000.00
Dec 31, 2021 33,000.00
Sep 30, 2021 28,000.00
API Access

Immunovant Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=IMVT&period=max&api_key=YOUR_API_KEY